Cat Hyperthyroid Post-Treatment Monitoring

Cats treated for hyperthyroidism with radioactive iodine, surgery or medication require careful monitoring for rebound hypothyroidism and concurrent kidney disease.

Key Facts

Up to 40% of cats treated for hyperthyroidism develop overt kidney disease after treatment normalises thyroid function
High thyroid hormone levels mask underlying chronic kidney disease by increasing glomerular filtration rate
Post-treatment monitoring should include thyroid levels, kidney function, blood pressure and weight at regular intervals
Radioactive iodine treatment is curative in over 95% of cases but requires careful monitoring for hypothyroidism
Over-treatment with medication or ablation causing hypothyroidism worsens kidney function and welfare

Welfare Considerations

The post-treatment phase of feline hyperthyroidism management is welfare-critical and often underestimated. A treated hyperthyroid cat that then develops severe kidney disease due to unmasking of pre-existing CKD experiences a significant welfare setback. Careful staging - evaluating kidney function on low-dose medical therapy before committing to ablative treatment - can identify cats most at risk and guide optimal management decisions.

What You Can Do

Ensure your vet checks kidney function before and after hyperthyroid treatment
Schedule follow-up monitoring at 3 and 6 weeks post-treatment, then every 3-6 months
Monitor for signs of hypothyroidism including lethargy, weight gain and poor coat quality
Work with your vet to find the lowest effective methimazole dose that avoids hypothyroidism
Discuss thyroid staging (trial medical therapy) with your vet before choosing ablative treatment